Mode
Text Size
Log in / Sign up

Vascular Dementia

Part of Dementia

7 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials for Vascular Dementia

21 trials tracked for Vascular Dementia: 4 in phase 3 or 4 and 1 with published results. The most-cited published study has 71 citations.

21Trials tracked
4Phase 3 & 4
0Recruiting
1With published results
Phase distribution
Phase 4 2 Phase 3 2 Phase 2 1 Other / NA 16
  1. Phase 3 The Healthy Patterns Sleep Study Completed · 71 cited
  2. Phase 4 A Clinical Trial to Evaluate the Safety and Efficacy of 20 ml Cerebrolysin in Patients With Vascular Dementia Completed
  3. Phase 4 Low-Dose Opiate Therapy for Discomfort in Dementia (L-DOT) Completed
  4. Phase 3 Prospekta in the Treatment of Cognitive, Behavioral and Psychiatric Disorders in Patients With Vascular Dementia. Completed
  5. Phase 2 Effect of Insulin Sensitizer Metformin on AD Biomarkers Completed
  6. N/A Zolpidem CR and Hospitalized Patients With Dementia Completed
Show 15 more trials
  1. N/A Palliative Care for Persons With Late-stage Alzheimer's and Related Dementias and Their Caregivers Completed
  2. N/A Cognitive Stimulation Therapy for Dementia: A Two-Armed Pragmatic Trial Completed
  3. N/A Efficacy Study of Kinto Care Coaching for Dementia Family Caregivers Completed
  4. N/A SAFE at Home: A Service to Provide Social Engagement to Community-Dwelling Persons With Dementia Completed
  5. N/A LEAD IT! An App to Enable Persons With Early Stage Dementia to Lead Group Activities for Their Peers Completed
  6. N/A Optimizing Dementia Care Completed
  7. N/A Non-Interventional Study With Aricept® Evess Completed
  8. N/A The BRAIN App: Building Relationships Using Artificial Intelligence and Nostalgia Completed
  9. N/A Rural Dementia Caregiver Project Completed
  10. N/A Cerebral Haemodynamic Changes During Cognitive Testing: A fTCD Study Completed
  11. N/A All About Me: An Intervention to Ease the Transition to Long Term Care Completed
  12. N/A Accurate WiFi-Based Localization of Dementia Patients For Caregiver Support: Completed
  13. N/A Care Ecosystem: Navigating Patients and Families Through Stages of Care Completed
  14. N/A Care of Persons With Dementia in Their Environments (COPE) in Programs of All-Inclusive Care of the Elderly (PACE) Completed
  15. N/A Innovations in Dementia Empowerment and Action Completed

Showing the 21 most-cited and recently-updated of 21 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

What the trials found Updated — new results For clinicians

Vascular Dementia: what the trials found

Pharmacological interventions for vascular dementia include Cerebrolysin, which demonstrated a significant improvement in ADAS-cog+ scores at week 24 compared to baseline (p < 0.0001) 3. Prospekta was associated with statistically significant improvements in MoCA scores (p = 0.0316) and Clinical Global Impression Efficacy Index (CGI-EI) scores (p = 0.0018), though it did not significantly impact Neuropsychiatric Inventory-Clinician (NPI-C) scores 5.

Behavioral and engagement programs, such as SAFE at Home, resulted in significant changes in both constructive and passive engagement on the Menorah Park Engagement Scale [10, 11].

Recent results — preliminary, needs further review

  • Cognitive Stimulation Therapy (CST) referral showed a statistically significant difference in cognitive impairment scores (p < 0.05), though only a small percentage of patients who were referred actually completed the therapy 1.
  • The ADRD-PC Program resulted in a statistically significant increase in symptom treatment for patients (p < 0.001), but did not show significant differences in hospital transfers or physical symptom control 7.
  • A Building Better Caregivers Workshop was evaluated regarding caregiver depression, stress, and self-efficacy, though specific p-values were not provided for these outcomes 8.

For the clinician treating this condition

  • Cerebrolysin and Prospekta have shown statistically significant improvements in cognitive assessment scales (ADAS-cog+ and MoCA respectively) [3, 5].
  • SAFE at Home programs are associated with measurable changes in patient engagement levels [10, 11].
  • While referral for Cognitive Stimulation Therapy is linked to improved outcomes, low completion rates may impact clinical implementation 1.

AI synthesis of 5 cited trials, updated Jun 29, 2026. Informational only — not medical advice; trial data sourced from ClinicalTrials.gov. How we use AI.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.

Research across Dementia

Related studies from across the Dementia family.

Pain assessment guidelines for cognitively impaired older adults lack practical detail
Anesthesiology & Pain Medicine Sys. Review
Pain assessment guidelines for cognitively impaired older adults lack practical detail Pain guidelines for dementia patients lack practical advice
This scoping review mapped pain assessment guidelines for hospitalized older adults with cognitive impairment. No Australian guidelines were…
A review finds most pain assessment guidelines for older adults with dementia offer little practical help for hospital staff.
Network meta-analysis protocol aims to rank structured exercise interventions for fall prevention in dementia
Rheumatology Meta-analysis
Network meta-analysis protocol aims to rank structured exercise interventions for fall prevention in dementia Exercise Programs May Help Prevent Falls in Seniors with Dementia
This is a protocol for a systematic review and network meta-analysis regarding structured exercise interventions for older adults with mild …
A planned review aims to determine which types of structured exercise best help older adults with memory loss stay safe and avoid falling.
Multidomain lifestyle interventions provide small but statistically significant benefits for global cognition scores
Neurology Meta-analysis
Multidomain lifestyle interventions provide small but statistically significant benefits for global cognition scores Multidomain lifestyle changes may help slow signs of dementia
This meta-analysis of randomized controlled trials involving 23209 participants found that multidomain lifestyle interventions (three or mor…
Combining multiple lifestyle habits like diet and exercise can lead to small but steady improvements in brain health for those at risk of de…
TBP expansion in SCA17 can cause dementia-like symptoms and requires etiological reconsideration
Neurology Sys. Review
TBP expansion in SCA17 can cause dementia-like symptoms and requires etiological reconsideration New Diagnosis for Dementia Patients with Spinocerebellar Ataxia Type 17
This case report and focused literature review describes a patient with SCA17 presenting as dementia, highlighting the need for genetic test…
A new look at dementia cases may reveal an underlying genetic condition called spinocerebellar ataxia type 17.
Adaptive immune signatures and T cell infiltration characterize pathology in Alzheimer's, Parkinson's, and Lewy Body dementia
Neurology Sys. Review
Adaptive immune signatures and T cell infiltration characterize pathology in Alzheimer's, Parkinson's, and Lewy Body dementia Adaptive Immune Signatures Linked to Alzheimer's and Parkinson's Disease
This mini review synthesizes evidence regarding adaptive immune remodeling and T cell responses in neurodegenerative dementias. The authors …
New research highlights how specific immune cell activity may play a role in the progression of Alzheimer's, Parkinson's, and Lewy body deme…
The osteoimmune-brain axis links systemic inflammation and bone hormones to neurodegenerative pathology
Allergy & Immunology Sys. Review
The osteoimmune-brain axis links systemic inflammation and bone hormones to neurodegenerative pathology Immune system may link bone health and brain disease
This systematic review examines the role of the osteoimmune-brain axis, where the immune system mediates skeletal and cerebral pathology thr…
A new look at the body's immune system suggests a link between bone health and conditions like Alzheimer's and dementia.
Rapid advancements in imaging and blood-based biomarkers are transforming the diagnosis and management of ADRD
Neurology Guideline
Rapid advancements in imaging and blood-based biomarkers are transforming the diagnosis and management of ADRD New guidelines help doctors tell delirium from dementia
This clinical guideline provides a narrative review on the evolving diagnostic and treatment landscape for Alzheimer's disease and related d…
Delirium is acute and fluctuating; dementia is chronic. New guidelines help doctors tell them apart.
Extended occupational therapy showed no significant improvement in behavioral symptoms for dementia patients
Physical Medicine & Rehab RCT
Extended occupational therapy showed no significant improvement in behavioral symptoms for dementia patients Extended occupational therapy shows no added benefit for dementia
This randomized controlled trial evaluated community-dwelling adults with mild-to-moderate dementia in France. Participants received occupat…
Adding four more months of occupational therapy did not improve behavioral symptoms in people with mild-to-moderate dementia, compared to st…
GLP-1 receptor agonists may reduce cognitive decline in type 2 diabetes patients with dementia
Neurology Meta-analysis
GLP-1 receptor agonists may reduce cognitive decline in type 2 diabetes patients with dementia GLP-1 drugs may slow cognitive decline in type 2 diabetes
A systematic review of systematic reviews and meta-analyses found that GLP-1 receptor agonists are associated with reduced overall cognitive…
A review of reviews suggests GLP-1 drugs like Ozempic may help protect memory and thinking in people with type 2 diabetes.
SLE linked to 53% higher odds of cognitive impairment in meta-analysis of 7 million
Rheumatology Meta-analysis
SLE linked to 53% higher odds of cognitive impairment in meta-analysis of 7 million Lupus linked to higher risk of cognitive decline
This meta-analysis of 7 observational studies involving over 7 million participants found that systemic lupus erythematosus (SLE) is signifi…
People with lupus may face 53% higher odds of cognitive impairment, a large analysis finds.
Dog-assisted therapy significantly improves behavioral symptoms in dementia patients compared to routine care in a systematic review
Physical Medicine & Rehab Meta-analysis
Dog-assisted therapy significantly improves behavioral symptoms in dementia patients compared to routine care in a systematic review Dog-assisted therapy improves behavior in dementia patients
This systematic review and meta-analysis of 10 randomized controlled trials evaluated dog-assisted therapy for patients with dementia. The p…
A meta-analysis suggests dog-assisted therapy may reduce behavioral symptoms in dementia patients, though evidence remains weak due to study…
Higher EAT-Lancet diet adherence linked to lower risks of depression, anxiety, stroke, and dementia in observational cohorts
Nutrition & Obesity Medicine Meta-analysis
Higher EAT-Lancet diet adherence linked to lower risks of depression, anxiety, stroke, and dementia in observational cohorts Eating healthy plant foods may lower risk of depression, anxiety, stroke, and dementia in older adults
This systematic review and meta-analysis examined associations between adherence to the EAT-Lancet diet and neuropsychiatric disorders acros…
A review of many studies found that following a plant-based diet like EAT-Lancet was linked to lower chances of depression, anxiety, stroke,…

Questions about Vascular Dementia

Is there a link between schizophrenia and the development of vascular dementia?

People with schizophrenia have a two- to threefold higher risk of developing dementia, including vascular dementia, due to shared biological factors and medical burdens.

Full answer →
How do antidiabetic drugs affect dementia risk in patients with diabetes?

Research shows that insulin, metformin, and pioglitazone lower dementia risk compared to placebo, while DPP4 inhibitors may increase vascular dementia risk compared to SGLT2 inhibitors.

Full answer →
Does having schizophrenia increase my chances of getting vascular dementia later?

Having schizophrenia increases your risk of developing dementia later in life by about two to three times, and this higher risk includes a specific increase in vascular dementia.

Full answer →